Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREP Trial: Probiotics for Radiotherapy Induced Enteropathy
NCT03978949Phase 3Unknown
- Sponsor
- Asan Medical Center
- Start
- Jun 2019
- Primary completion
- Aug 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bacillus licheniformis in Radiation Enteropathy (PRD) (2 arms), sponsored by Asan Medical Center. Primary endpoint: Number of participants with grade 2 or more acute intestinal toxicities. Status: unknown.
02
Drugs
bacillus licheniformis
03
Conditions
Radiation Enteropathy (PRD)
Beyond the preview
Go deeper on NCT03978949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03978949.